1-2 of 2
Jennifer Byrne, FRCP, FRCPath, PhD
Close
Sort by
Journal Articles

Phazar: A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN [ISRCTN16783472]

Mark W. Drummond, PhD FRCPath, Charlotte Gaskell, BSc, MSc, Claire Harrison, DM, FRCP, FRCPath, Adam J. Mead, MD PhD, Christina Yap, PhD CStat, Aimee E Jackson, BSc, MSc, Jennifer Byrne, FRCP, FRCPath, PhD, Fiona J Clark, FRCP, FRCPath, Srinivasan Narayanan, FRCP, FRCPath, David Bowen, MD, Tim C.P Somervaille, PhD FRCP, FRCPath, Emma Gudgin, MBBS, MRCP, FRCPath, PhD, Dragana Milojkovic, Rachel S Fletcher, PhD, Charlotte K Brierley, MRCP, MD, Steve Knapper, BMBCh, MRCP, FRCPath, DM
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-138437
Published: 2020
Journal Articles

Does a Change in IPSS-R between Diagnosis and Transplant Have an Impact on Transplant Outcome in Patients with MDS? a Retrospective Analysis from the EBMT Chronic Malignancies Working Party

Christof Scheid, MD, Dirk-Jan Eikema, Riitta Niittyvuopio, Johan Maertens, Jakob Passweg, Didier Blaise, MD, Jennifer Byrne, FRCP, FRCPath, PhD, Nicolaus Kröger, Martin Bornhäuser, MD, Patrice Chevallier, MD PhD, Jean-Henri Bourhis, Jan J. Cornelissen, MD PhD, Henrik Sengeloev, Jürgen Finke, Sr., MD PhD, John A Snowden, MD PhD, Tobias Gedde-Dahl, Denis Guyotat, MD PhD, Urs Schanz, MD, Amit Patel, PhD, Linda Koster, Liesbeth C. de Wreede, PhD, Patrick J Hayden, MD, Francesco Onida, MD, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-141792
Published: 2020